Sort   by:  
 Page size 
ProteomicsCOVIDomics_plasma_2020_DDA-PASEF
In order to investigate variations in the endotype of COVID19 patients, we completed an integrated analysis of 112 research participants, including 74 COVID19 patients versus 37 SARS-CoV-2 negative controls. COVID19 patients tested positive for SARS-CoV-2 infection by PCR and/or antibody testing and...
ORGANISM(S): Homo sapiens (Human) 
2021-03-04 | PXD022817 | Pride
Multi-omics Plasma Covid-19 
UnknownThe COVIDome Explorer Researcher Portal.
Not available
S-EPMC7987038 | biostudies-literature
UnknownSpecialized interferon action in COVID-19.
Not available
S-EPMC8931386 | biostudies-literature
ProteomicsDrug Induced Liver Injury Biomarker Discovery Data
Discovery proteomics was conducted on serum samples using tandem mass tagging for relative quantitation to discover potential new biomarkers of DILI.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2022-07-01 | MSV000089782 | MassIVE
GenomicsGenome Wide Profiling of p53 Response to Differentiation or DNA Damage of Human Embryonic Stem Cells
Tumor suppressor p53 promotes differentiation of human embryonic stem cells (hESCs), but an in-depth understanding of mechanism is lacking. Here, we define p53 functions in hESCs by genome wide profiling of p53 chromatin interactions and intersection with gene expression during early differentiation...
ORGANISM(S): Homo sapiens 
2013-10-18 | E-GEOD-39912 | biostudies-arrayexpress
GenomicsEGAS00001000224-sc-20121128 - samples
Agilent whole exome hybridisation capture was performed on genomic DNA derived from MDS and matched normal DNA from the same patients. Next Generation sequencing performed on the resulting exome libraries and mapped to build 37 of the human reference genome to facilitate the identification of novel ...
EGAD00001000283 | EGA
GenomicsEGAS00001000089-sc-20120216 - samples
Myelodysplastic Syndrome Exome Sequencing
EGAD00001000117 | EGA
GenomicsEGAS00001000089-sc-20111014 - samples
Somatic mutation of SF3B1 in myelodysplasia with ring sideroblasts and other cancers
EGAD00001000045 | EGA
GenomicsMyelodysplastic Syndrome Exome Sequnecing
Cancer is driven by mutation. Illumina GA massively parallel sequencing technology will be applied to Agilent exome hybridisation capture libraries and total genomic paired-end libraries. Bespoke algorithms are being developed to identify the somatically acquired structural variants, point mutations...
EGAS00001000089 | EGA
GenomicsICGC Data Access Compliance Office
To access Controlled Access ICGC data at the EGA you must first apply for access on the DACO form. Instructions on this process is available from this web site: http://docs.icgc.org/portal/access/
EGAC00001000010 | EGA
Sort   by:  
 Page size